GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rossari Biotech ROSSARI.NS · INR

Materials · NSE · 🇮🇳 India

Compare

424.95

-0.55%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹23.96bn

FY2017FY2026

Net income

₹1.49bn

FY2017FY2026

Free cash flow

−₹2.20bn

FY2017FY2026

Shareholders' equity

₹13.33bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹23.96bn₹20.80bn₹18.31bn₹16.56bn₹14.83bn₹7.07bn₹5.98bn₹5.13bn₹2.91bn₹2.35bn
Research and development—₹78.3m₹70.2m₹82.5m₹59.5m₹75.0m₹53.5m₹38.6m₹31.4m₹47.1m
Operating income₹2.07bn₹5.15bn₹1.87bn₹1.55bn₹1.45bn₹1.08bn₹879.6m₹656.4m₹375.7m₹197.4m
Net income₹1.49bn₹1.36bn₹1.31bn₹1.07bn₹976.7m₹802.2m₹652.5m₹456.8m₹254.0m₹142.8m
Diluted earnings per share26.9124.5923.5819.3717.6114.4912.429.264.582.58

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹22.89bn₹18.96bn₹15.72bn₹13.68bn₹12.57bn₹5.61bn₹4.72bn₹2.50bn₹1.65bn₹1.31bn
Cash and short-term investments₹1.27bn₹1.14bn₹708.1m₹1.52bn₹644.3m₹883.6m₹1.45bn₹64.0m₹79.2m₹22.1m
Total liabilities₹9.55bn₹7.11bn₹5.24bn₹4.52bn₹4.52bn₹1.53bn₹1.85bn₹1.26bn₹778.7m₹689.1m
Debt₹4.36bn₹2.18bn₹1.19bn₹739.3m₹84.3m₹84.3m₹669.3m₹45.3m₹209.5m₹255.7m
Shareholders' equity₹13.33bn₹11.85bn₹10.48bn₹9.15bn₹8.05bn₹4.09bn₹2.87bn₹1.24bn₹870.8m₹619.9m
Shares outstanding55m55m55m55m55m55m53m49m55m55m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹451.6m₹1.37bn₹432.6m₹1.52bn₹293.6m₹477.7m₹548.3m₹711.8m₹255.7m₹47.0m
Capital spending−₹2.65bn−₹1.59bn−₹1.31bn−₹328.8m−₹382.3m−₹580.8m−₹759.7m−₹439.9m−₹139.3m−₹39.1m
Free cash flow−₹2.20bn−₹210.7m−₹880.3m₹1.20bn−₹88.7m−₹103.2m−₹211.4m₹271.9m₹116.4m₹7.8m
Dividends paid−₹27.7m−₹27.6m−₹27.6m−₹27.5m−₹27.5m−₹25.4m−₹26.5m−₹105.9m−₹2.6m−₹2.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹6.97bn₹6.85bn₹5.82bn₹5.86bn₹5.44bn₹5.80bn₹5.13bn₹4.98bn
Operating income₹550.0m₹537.2m₹492.6m₹536.9m₹501.1m₹1.42bn₹464.4m₹507.8m
Net income₹350.9m₹459.7m₹327.7m₹368.8m₹336.0m₹344.4m₹317.0m₹353.3m
Diluted earnings per share6.338.295.916.656.066.215.726.38
Cash from operations———−₹250.0m————
Capital spending———−₹1.42bn————
Free cash flow———−₹1.67bn————
Total assets—₹22.89bn—₹20.88bn—₹18.96bn—₹17.11bn
Cash and short-term investments₹1.15bn₹1.27bn₹767.9m₹719.8m₹1.17bn₹1.14bn₹800.1m₹842.3m
Debt—₹4.16bn—₹2.13bn—₹1.96bn—₹1.46bn
Shareholders' equity₹13.33bn₹13.33bn₹12.51bn₹12.51bn₹11.85bn₹11.85bn₹11.18bn₹11.18bn

Financial ratios

Data as of 22 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin8.6%24.7%10.2%9.4%9.8%15.3%—
Net margin6.2%6.6%7.1%6.5%6.6%11.3%—
Return on equity11.2%11.5%12.5%11.7%12.1%19.6%—
Return on assets6.5%7.2%8.3%7.8%7.8%14.3%—
Free cash flow yield12.6%12.1%7.1%7.6%2.8%4.3%—
Revenue growth15.2%13.6%10.5%11.7%109.6%18.3%—
Earnings growth9.4%4.4%21.8%9.8%21.8%22.9%—
Current ratio1.57x1.94x1.99x2.08x2.07x2.36x—
Debt to equity0.31x0.17x0.10x0.08x0.01x0.01x—
Equity ratio58.3%62.5%66.6%66.9%64.1%72.8%—
Interest coverage7.24x28.90x9.63x6.95x11.43x36.15x—
R&D as a share of sales—0.4%0.4%0.5%0.4%1.1%0.9%
Buybacks as a share of market value0.0%-0.1%-0.1%0.2%-0.2%-5.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.1%27.6%29.7%
Operating income10.1%13.8%38.7%
Net income11.6%13.2%45.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin16.1%13.3%13.0%12.8%
Net margin6.4%6.6%6.9%7.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings15.823.733.041.341.388.675.7
Price to sales1.01.62.42.72.710.18.3

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 10 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022
Paid in the year0.500.500.500.500.500.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.